SARS-CoV-2-antibodies may promote severe COVID-19
According to a new study by Willianne Hoepel and colleagues from Amsterdam UMC, serum taken from patients with severe COVID-19 had an increased level...
Swiss Oculis SA raises $57m in Series C
The financing was co-led by new investors BVCF Management and Hyfinity Investments, with VI Partners and Wille AG joining the company’s existing...
Abingworth raises $582m for late-stage fund ACCD 2
Abingworth Clinical Co-Development Fund 2 (ACCD 2) was significantly oversubscribed, exceeding its target of US$350m. The ACCD 2 fund provides...
Record year for Swiss biotech industry
Driven by the corona crisis, the Swiss biotech ecosystem is thriving as never before. This is evidenced by the Swiss Biotech Report from EY, the...
BioPhero A/S raises US$17m in Series A funding
New investor exFMC Ventures, as well as existing investors Syngenta Group Ventures and Novo Holdings also participated in the...
Next-gen COVID-19 vaccine good in preclinical tests
In contrast to injectable vaccines, the nasal jab seems capablet to induce mucosal immunity which is crucial to eliminate the virus instead only...
DNA Script bags DARPA funding
The DARPA money will be invested to establish a partnership of DNA Script with the mRNA vaccine specialist Moderna, Inc. to develop a prototype for...